IPN, Delhi, India. Open 10-6pm

+91 9891296838 / 9811747774

Indian Pharma Network (IPN)

Medicines For Lung Cancer Treatment

IPN, New Delhi can facilitate lung cancer patient to “import of  Medicines For Lung Cancer Treatment” for personal use under “patient name basis” treatment in India. For this applicant is required to make an request application with required document. IPN, New Delhi will do the necessary process to obtain permission from Drugs Controller General (India) to import.

Indian Pharma Network

M: +91-9891296838 / 9811747774
E:  med@indianpharmanetwork.co.in

Lung Cancer Treatment

Lung cancer is a type of cancer that starts in the lungs. There are two main types of lung cancer: non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC). Treatment options for lung cancer depend on the type and stage of the cancer, as well as the patient’s overall health. Some common treatment options for lung cancer include: Surgery, Radiation therapy, Chemotherapy, Targeted therapy, mmunotherapy.

Get Access FDA Approved Medicines For Lung Cancer Treatment

Chemotherapy drugs are often used in the treatment of lung cancer, especially for non-small cell lung cancer (NSCLC) or advanced-stage small cell lung cancer (SCLC). Chemotherapy uses drugs to kill rapidly dividing cancer cells, and can be given intravenously or orally.

Some common chemotherapy drugs used in the treatment of lung cancer include:

  • Platinum-containing agents: Cisplatin | Carboplatin | Oxaliplatin
  • Taxanes: Paclitaxel | Docetaxel
  • Antimetabolites: Gemcitabine | Pemetrexed | Capecitabine
  • Vinca alkaloids: Vinorelbine | Topoisomerase
  • inhibitors: Etoposide | Irinotecan | Topotecan.

Chemotherapy drugs can be used alone or in combination with other treatments such as surgery, radiation therapy, targeted therapy or immunotherapy. The specific chemotherapy drug or combination of drugs used will depend on the individual patient’s needs and the stage of their cancer. It is important to discuss treatment options with a healthcare provider.

Targeted therapy drugs are a type of cancer treatment that work by targeting specific molecules or genes that are present in cancer cells. These drugs are designed to attack cancer cells while minimizing damage to normal cells.

Some common targeted therapy drugs used in the treatment of lung cancer include:

  • Epidermal growth factor receptor (EGFR) inhibitors: Erlotinib | Gefitinib | Afatinib | Osimertinib
  • Anaplastic lymphoma kinase (ALK) inhibitors: Crizotinib  | Alectinib | Brigatinib | Ceritinib | Lorlatinib
  • ROS1 inhibitors: Crizotinib
  • Vascular endothelial growth factor (VEGF) inhibitors: Bevacizumab | Ramucirumab
  • Programmed cell death protein 1 (PD-1) inhibitors: Pembrolizumab | Nivolumab \ Durvalumab

Targeted therapy drugs are typically given orally and are often used to treat advanced stage non-small cell lung cancer (NSCLC). They may be used alone or in combination with other treatments such as chemotherapy or radiation therapy. The specific targeted therapy drug or combination of drugs used will depend on the individual patient’s needs and the stage of their cancer. It is important to discuss treatment options with a healthcare provider.

Immunotherapy drugs are a type of cancer treatment that work by boosting the immune system to help it recognize and attack cancer cells. They are often used in the treatment of lung cancer, especially in cases where other treatments such as chemotherapy or radiation therapy have not been effective.

Some common immunotherapy drugs used in the treatment of lung cancer include:

  • Programmed cell death protein 1 (PD-1) inhibitors: Pembrolizumab \ Nivolumab
  • Programmed cell death ligand 1 (PD-L1) inhibitors: Atezolizumab | Durvalumab
  • Cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) inhibitors: Ipilimumab

Immunotherapy drugs are typically given by intravenous infusion and can be used alone or in combination with other treatments such as chemotherapy or radiation therapy. They are often used to treat advanced stage non-small cell lung cancer (NSCLC). The specific immunotherapy drug or combination of drugs used will depend on the individual patient’s needs and the stage of their cancer. It is important to discuss treatment options with a healthcare provider.

Steroids may be used to help reduce inflammation and swelling caused by cancer or cancer treatment.

The specific medication or combination of medications used in the treatment of lung cancer will depend on the individual patient’s needs and the stage of their cancer. It is important to discuss treatment options with a healthcare provider.

Legitimate Healthcare Consultant and Facilitator In Delhi

If you have a question relating to anti-cancer medicines approved for treatment of Lung Cancer, a problem which you do not know how to resolve it, or concrete inquiry – we are here for you. We will answer you via email urgent@indianpharmanetwork.co.in  as soon as possible. If you prefer to be contacted by phone, please leave your phone number. Or text your message in WhatsApp Number +91 9891296838 / 9811747774.

Contact Info

CORPORATE OFFICE:
Basement-B-5-A, Ajit Singh House Building No.12, Yusuf Sarai, South Delhi,
New Delhi:110016 India.

MOBILE / PHONE NUMBER:
M: +91 9811747774, 9891296838.
P / F: +91-11-26532129 / 26536398

EMAIL ID:
info@indianpharmanetwork.co.in

FAX NUMBER:
+91-11-26532129

Query Form For Medications

Indian Pharma Network (IPN), New Delhi. India

Indian Pharma Network (IPN) is registered organisation in India, having highly qualified healthcare professionals of pharmaceutical Industry. Specialized in Oncology Products. Helped more than 6,000 patients. Registration Number : 07AAFFI2544E1ZO under GST Act.
Branch Offices in India : New Delhi | Bengaluru | Kolkata | Lucknow | Jaipur | Jodhpur.
Our Overseas Network UK | Russia | Brazil | Mexico | Germany | France| Italy | Spain | Japan | China| Australia | Brazil | Saudi Arabia | South Africa

Indian Pharma Network
60/4 1st Floor, T&T Building, Indian Oil Complex, Yusuf Sarai, New Delhi, Delhi 110016

Mobile / WhatsApp / Phone
M: +91 9811747774, 9891296838.
P: +91-11-26532129 / 26536398